These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 19780876

  • 1. Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD.
    Zheng L, Lv GC, Sheng J, Yang YD.
    J Gastroenterol Hepatol; 2010 Jan; 25(1):156-63. PubMed ID: 19780876
    [Abstract] [Full Text] [Related]

  • 2. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE, Choi KM, Baik SH, Kim KO, Lim HJ, Park KH, Kim JY, Park JJ, Kim JS, Bak YT, Byun KS, Lee CH.
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [Abstract] [Full Text] [Related]

  • 3. Transition from hepatic steatosis to steatohepatitis: unique microRNA patterns and potential downstream functions and pathways.
    Jin X, Chen YP, Kong M, Zheng L, Yang YD, Li YM.
    J Gastroenterol Hepatol; 2012 Feb; 27(2):331-40. PubMed ID: 21793903
    [Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A, Pazienza V, Pugnale P, Bruttin F, Rubbia-Brandt L, Juge-Aubry CE, Meier CA, Hadengue A, Negro F.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):107-14. PubMed ID: 16393287
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M, Kohjima M, Morizono S, Kotoh K, Yoshimoto T, Miyagi I, Enjoji M.
    Int J Mol Med; 2005 Oct 01; 16(4):631-5. PubMed ID: 16142397
    [Abstract] [Full Text] [Related]

  • 6. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 01; 20(8):598-604. PubMed ID: 23207154
    [Abstract] [Full Text] [Related]

  • 7. Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.
    Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH.
    Acta Physiol (Oxf); 2008 Sep 01; 194(1):57-65. PubMed ID: 18394026
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes.
    Ricchi M, Odoardi MR, Carulli L, Anzivino C, Ballestri S, Pinetti A, Fantoni LI, Marra F, Bertolotti M, Banni S, Lonardo A, Carulli N, Loria P.
    J Gastroenterol Hepatol; 2009 May 01; 24(5):830-40. PubMed ID: 19207680
    [Abstract] [Full Text] [Related]

  • 9. Decreased expression of peroxisome proliferator-activated receptor alpha and liver fatty acid binding protein after partial hepatectomy of rats and mice.
    Skrtic S, Carlsson L, Ljungberg A, Lindén D, Michalik L, Wahli W, Oscarsson J.
    Liver Int; 2005 Feb 01; 25(1):33-40. PubMed ID: 15698396
    [Abstract] [Full Text] [Related]

  • 10. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS, Kim JH, Jo NY, Choi KM, Baik SH, Park JJ, Kim JS, Byun KS, Bak YT, Lee CH, Kim A, Yeon JE.
    J Gastroenterol Hepatol; 2008 Jan 01; 23(1):102-9. PubMed ID: 18171348
    [Abstract] [Full Text] [Related]

  • 11. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis.
    Sharma MR, Polavarapu R, Roseman D, Patel V, Eaton E, Kishor PB, Nanji AA.
    Exp Mol Pathol; 2006 Dec 01; 81(3):202-10. PubMed ID: 16949573
    [Abstract] [Full Text] [Related]

  • 12. Differential gene expression profiling of the molar tooth germ in peroxisome proliferator-activated receptor-alpha (PPAR-alpha) knockout mouse and in wild-type mouse: molar tooth phenotype of PPAR-alpha knockout mouse.
    Sehic A, Khuu C, Risnes S, Osmundsen H.
    Eur J Oral Sci; 2009 Apr 01; 117(2):93-104. PubMed ID: 19320717
    [Abstract] [Full Text] [Related]

  • 13. ERp57 is up-regulated in free fatty acids-induced steatotic L-02 cells and human nonalcoholic fatty livers.
    Wang H, Chan PK, Pan SY, Kwon KH, Ye Y, Chu JH, Fong WF, Tsui WM, Yu ZL.
    J Cell Biochem; 2010 Aug 15; 110(6):1447-56. PubMed ID: 20506389
    [Abstract] [Full Text] [Related]

  • 14. Endoplasmic reticulum stress involved in the course of lipogenesis in fatty acids-induced hepatic steatosis.
    Liu J, Jin X, Yu CH, Chen SH, Li WP, Li YM.
    J Gastroenterol Hepatol; 2010 Mar 15; 25(3):613-8. PubMed ID: 19929925
    [Abstract] [Full Text] [Related]

  • 15. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
    Harano Y, Yasui K, Toyama T, Nakajima T, Mitsuyoshi H, Mimani M, Hirasawa T, Itoh Y, Okanoue T.
    Liver Int; 2006 Jun 15; 26(5):613-20. PubMed ID: 16762007
    [Abstract] [Full Text] [Related]

  • 16. Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-alpha.
    Huang TH, Peng G, Li GQ, Yamahara J, Roufogalis BD, Li Y.
    Toxicol Appl Pharmacol; 2006 Feb 01; 210(3):225-35. PubMed ID: 15975614
    [Abstract] [Full Text] [Related]

  • 17. Aberrant miR199a-5p/caveolin1/PPARα axis in hepatic steatosis.
    Li B, Zhang Z, Zhang H, Quan K, Lu Y, Cai D, Ning G.
    J Mol Endocrinol; 2014 Dec 01; 53(3):393-403. PubMed ID: 25312970
    [Abstract] [Full Text] [Related]

  • 18. Identification of promethin and PGLP as two novel up-regulated genes in PPARgamma1-induced adipogenic mouse liver.
    Yu S, Viswakarma N, Batra SK, Sambasiva Rao M, Reddy JK.
    Biochimie; 2004 Nov 01; 86(11):743-61. PubMed ID: 15589683
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH, Chew GS, Najimudin N, Tengku-Muhammad TS.
    Int J Biochem Cell Biol; 2007 Nov 01; 39(10):1975-86. PubMed ID: 17616429
    [Abstract] [Full Text] [Related]

  • 20. Differential induction of genes in liver and brown adipose tissue regulated by peroxisome proliferator-activated receptor-alpha during fasting and cold exposure in acyl-CoA dehydrogenase-deficient mice.
    Goetzman ES, Tian L, Wood PA.
    Mol Genet Metab; 2005 Jan 01; 84(1):39-47. PubMed ID: 15639194
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.